Literature DB >> 18536704

Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum.

Theresa Currier Thomas1, David K Grandy, Greg A Gerhardt, Paul E A Glaser.   

Abstract

To better understand the effect of the dopamine D4 receptor (DRD4) on glutamate (Glu) neurotransmission in the brain, we utilized transgenic mice with partial or complete removal of functional DRD4 plasma membrane expression (DRD4+/- and DRD4-/-, respectively). We measured resting extracellular Glu levels, Glu clearance kinetics, and KCl-evoked release of Glu in the striatum and nucleus accumbens core of these mice using in vivo amperometry coupled to a novel microelectrode array configured for sub-second detection of Glu. Recordings from DRD4-/- and DRD4+/- mice were compared with their wild-type littermates (DRD4+/+). Resting extracellular levels of Glu were increased in the striatum of DRD4-/- mice (p<0.01). Glu clearance kinetics were significantly decreased in the dorsal striatum of DRD4-/- mice (p<0.05). KCl-evoked overflow of Glu was reliably measured but unchanged in the striatum of the three groups. By contrast, no changes in resting Glu, Glu uptake kinetics, or KCl-evoked release of Glu were observed in the nucleus accumbens core among the three genotypes. These data indicate that the DRD4 receptor is involved in modulation of Glu neurotransmission, primarily in the striatum. A better understanding of Glu control by the DRD4 may improve our understanding of the physiological role of the DRD4 in disorders such as attention-deficit/hyperactivity disorder and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536704      PMCID: PMC7223095          DOI: 10.1038/npp.2008.74

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  59 in total

1.  Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS.

Authors:  Jason J Burmeister; Francois Pomerleau; Michael Palmer; Brian K Day; Peter Huettl; Greg A Gerhardt
Journal:  J Neurosci Methods       Date:  2002-09-30       Impact factor: 2.390

2.  Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis.

Authors:  Philip Seeman; David Weinshenker; Remi Quirion; Lalit K Srivastava; Sanjeev K Bhardwaj; David K Grandy; Richard T Premont; Tatyana D Sotnikova; Patricia Boksa; Mufida El-Ghundi; Brian F O'dowd; Susan R George; Melissa L Perreault; Pekka T Männistö; Siobhan Robinson; Richard D Palmiter; Teresa Tallerico
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-16       Impact factor: 11.205

3.  Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats.

Authors:  K Zhang; F I Tarazi; R J Baldessarini
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

4.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain.

Authors:  L Mrzljak; C Bergson; M Pappy; R Huff; R Levenson; P S Goldman-Rakic
Journal:  Nature       Date:  1996-05-16       Impact factor: 49.962

5.  Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.

Authors:  P F Behrens; P Franz; B Woodman; K S Lindenberg; G B Landwehrmeyer
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

6.  A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.

Authors:  J B Lichter; C L Barr; J L Kennedy; H H Van Tol; K K Kidd; K J Livak
Journal:  Hum Mol Genet       Date:  1993-06       Impact factor: 6.150

7.  Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.

Authors:  Normand Carrey; Frank P MacMaster; Joshua Fogel; Sandra Sparkes; Dan Waschbusch; Sara Sullivan; Mathias Schmidt
Journal:  Clin Neuropharmacol       Date:  2003 Jul-Aug       Impact factor: 1.592

8.  In vivo electrochemical demonstration of potassium-evoked monoamine release from rat cerebellum.

Authors:  G A Gerhardt; G M Rose; B J Hoffer
Journal:  Brain Res       Date:  1987-06-16       Impact factor: 3.252

9.  Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.

Authors:  Normand J Carrey; Frank P MacMaster; Laura Gaudet; Matthias H Schmidt
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-02       Impact factor: 2.576

10.  A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura.

Authors:  Sara Campos de Sousa; Andreas Karwautz; Christian Wöber; Gudrun Wagner; Gerome Breen; Heidi-Elisabeth Zesch; Andrea Konrad; Arno Zormann; Christian Wanner; Christian Kienbacher; David A Collier; Ciçek Wöber-Bingöl
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

View more
  19 in total

1.  Hypersensitive glutamate signaling correlates with the development of late-onset behavioral morbidity in diffuse brain-injured circuitry.

Authors:  Theresa Currier Thomas; Jason M Hinzman; Greg A Gerhardt; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2011-12-01       Impact factor: 5.269

2.  The role of glutamate signaling in incentive salience: second-by-second glutamate recordings in awake Sprague-Dawley rats.

Authors:  Seth R Batten; Francois Pomerleau; Jorge Quintero; Greg A Gerhardt; Joshua S Beckmann
Journal:  J Neurochem       Date:  2018-05-15       Impact factor: 5.372

3.  Glutaraldehyde cross-linked glutamate oxidase coated microelectrode arrays: selectivity and resting levels of glutamate in the CNS.

Authors:  Jason J Burmeister; Verda A Davis; Jorge E Quintero; Francois Pomerleau; Peter Huettl; Greg A Gerhardt
Journal:  ACS Chem Neurosci       Date:  2013-05-09       Impact factor: 4.418

4.  Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus.

Authors:  Theresa Currier Thomas; Joshua A Beitchman; Francois Pomerleau; Teresa Noel; Paiboon Jungsuwadee; D Allan Butterfield; Daret K St Clair; Mary Vore; Greg A Gerhardt
Journal:  Brain Res       Date:  2017-07-11       Impact factor: 3.252

5.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

Review 6.  Electrochemical techniques for subsecond neurotransmitter detection in live rodents.

Authors:  Kevin N Hascup; Erin R Hascup
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

7.  Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study.

Authors:  Jason M Hinzman; Theresa Currier Thomas; Jason J Burmeister; Jorge E Quintero; Peter Huettl; Francois Pomerleau; Greg A Gerhardt; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

8.  The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.

Authors:  Jared W Young; Susan B Powell; Christine N Scott; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

9.  Effect of memantine on resting state default mode network activity in Alzheimer's disease.

Authors:  Marco Lorenzi; Alberto Beltramello; Nicola B Mercuri; Elisa Canu; Giada Zoccatelli; Francesca B Pizzini; Franco Alessandrini; Maria Cotelli; Sandra Rosini; Daniela Costardi; Carlo Caltagirone; Giovanni B Frisoni
Journal:  Drugs Aging       Date:  2011-03-01       Impact factor: 3.923

10.  Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability.

Authors:  Xiaodong Bao; Ranu Pal; Kevin N Hascup; Yongfu Wang; Wen-Tung Wang; Wenhao Xu; Dongwei Hui; Abdulbaki Agbas; Xinkun Wang; Mary L Michaelis; In-Young Choi; Andrei B Belousov; Greg A Gerhardt; Elias K Michaelis
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.